Clinical Trials
Hormone Related Testing Reagents Clinical Trial Analysis
| Publication Date | July 2009 |
| Publisher | Global Markets Direct |
| Product Type | |
| Pages | 20 |
| ISBN Number | not applicable |
| Product Code | GMD02899 |
Summary
Global Markets Direct's "Hormone Related Testing Reagents Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Hormone Related Testing Reagents manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.
Scope
- The report provides analysis and review of the key clinical trials being carried out globally and across key Hormone Related Testing Reagents market categories - Specific Proteins,Fertility and Pregnancy,Individual/ Specified hormones,Specific Organ Function
- The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
- The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.
Reasons to Buy
- Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
- Stay ahead of the information curve in the fast changing Hormone Related Testing Reagents market.
- Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
- Stay ahead of competition by understanding the changing competitive landscape in specific geographies.
Contents
- 1 List of Tables
- 1.2 List of Figures
- 2 Hormone Related Testing Reagents Clinical Trials
- 2.1 Hormone Related Testing Reagents Clinical Trial By Equipment Type
- 2.2 Hormone Related Testing Reagents Clinical Trials By Trial Phase and Trial Status
- 2.3 Hormone Related Testing Reagents Pipeline Products By Development Stage
- 2.4 Hormone Related Testing Reagents Pipeline Products By Therapy Area
- 2.5 Hormone Related Testing Reagents Pipeline Products By News Summary
- 2.6 Hormone Related Testing Reagents Urine One Step LH Test
- 2.6.1 Urine test (Ovulation) Clinical Trial
- 2.7 Hormone Related Testing Reagents Growth Hormone Secretagogue diagnostic
- 2.7.1 A Multi-Center, Randomized, Cross-Over Study Investigating A New, Oral Growth Hormone Secretagogue (GHS)(ARD-07) As A Growth Hormone (GH) Stimulation Test In Terms Of Safety And Efficacy Compared To L-ARG+GHRH
- 2.8 Hormone Related Testing Reagents MR-proADM Test
- 2.8.1 To Evaluate The Diagnostic And Prognostic Accuracy Of B Biomarkers
- 2.9 Hormone Related Testing Reagents MR-proANP Test
- 2.9.1 To Evaluate The Diagnostic And Prognostic Accuracy Of B Biomarkers
- 3 Recent Developments
- 3.1 Product News
- 3.1.1 Apr 10, 2009: FDA Grants Approval To Market Olympus' Alpha-Fetoprotein Assay For AU3000i Immunoassay System In US
- 3.1.2 Feb 25, 2009: B Submits MR-proANP Kryptor For FDA Approval
- 3.1.3 Nov 13, 2008: B Announces New Blood Test Better Predicts Heart Failure Outcomes In Emergency Setting
- 3.2 Product Approvals
- 3.2.1 Apr 10, 2009: FDA Grants Approval To Market Olympus' Alpha-Fetoprotein Assay For AU3000i Immunoassay System In US
- 3.3 Clinical Trials
- 3.3.1 Nov 13, 2008: B Announces New Blood Test Better Predicts Heart Failure Outcomes In Emergency Setting
- 3.1 Product News
- 4 Appendix
- 4.1 Methodology
- 4.1.1 Coverage
- 4.1.2 Secondary Research
- 4.1.3 Primary Research
- 4.1.4 Expert Panel Validation
- 4.2 Contact Us
- 4.3 About Global Markets Direct
- 4.4 Disclaimer
- 4.1 Methodology
- 1 List of Tables
- Table 1: Hormone Related Testing Reagents Clinical Trial By Equipment Type
- Table 2: Hormone Related Testing Reagents Clinical Trials By Trial Phase and Trial Status
- Table 3: Hormone Related Testing Reagents Pipeline Products By Development Stage
- Table 4: Hormone Related Testing Reagents Pipeline Products By Therapy Area
- Table 5: Hormone Related Testing Reagents Pipeline Products By News Summary
- Table 6: Urine One Step LH Test - Urine test (Ovulation) Clinical Trial
- Table 7: Growth Hormone Secretagogue diagnostic - A Multi-Center, Randomized, Cross-Over Study Investigating A New, Oral Growth Hormone Secretagogue (GHS)(ARD-07) As A Growth Hormone (GH) Stimulation Test In Terms Of Safety And Efficacy Compared To L-ARG+GHRH
- Table 8: MR-proADM Test - To Evaluate The Diagnostic And Prognostic Accuracy Of B Biomarkers
- Table 9: MR-proANP Test - To Evaluate The Diagnostic And Prognostic Accuracy Of B Biomarkers
- 1.2 List of Figures
- Figure 1: Global Markets Direct Methodology







